These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 17621734

  • 1. Physician's awareness of the prevention of corticosteroid induced osteoporosis.
    Ungprasert S, Wangkaew S, Louthrenoo W.
    J Med Assoc Thai; 2007 Jan; 90(1):59-64. PubMed ID: 17621734
    [Abstract] [Full Text] [Related]

  • 2. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
    Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD.
    J Rheumatol; 2004 Mar; 31(3):550-6. PubMed ID: 14994404
    [Abstract] [Full Text] [Related]

  • 3. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD, Cheah SP, Taylor K, Ahern MJ.
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C, Vij AS.
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT, Yosipovitch G.
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [Abstract] [Full Text] [Related]

  • 12. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ.
    Arthritis Rheum; 2007 Feb 15; 57(1):140-6. PubMed ID: 17266078
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Corticosteroid-induced osteoporosis.
    Miah S, Taylor R, McKellar G, Hunter J.
    Rheumatology (Oxford); 2003 Sep 15; 42(9):1118-20; author reply 1120. PubMed ID: 12923272
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, McIlwain HH, Freeman PG, Aranow C, Petri MA, Deodhar AA, Blanton E, Manzi S, Kavanaugh A, Lisse JR, Ramsey-Goldman R, McKay JD, Kivitz AJ, Mease PJ, Winkler AE, Kahl LE, Lee AH, Furie RA, Strand CV, Lou L, Ahmed M, Quarles B, Schwartz KE.
    J Rheumatol; 2008 Aug 15; 35(8):1567-75. PubMed ID: 18634158
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care.
    Nielsen BR, Jørgensen NR, Schwarz P.
    J Asthma; 2008 Aug 15; 45(6):519-22. PubMed ID: 18612907
    [Abstract] [Full Text] [Related]

  • 19. Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe.
    Hart SR, Green B.
    Postgrad Med J; 2002 Apr 15; 78(918):242-3. PubMed ID: 11930029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.